Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bortezomib
Therapeutic Area : Oncology
Study Phase : Phase II
Recipient : Instituto do Cancer do Estado de São Paulo
Deal Size : Inapplicable
Deal Type : Inapplicable
Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 13, 2023
Lead Product(s) : Bortezomib
Therapeutic Area : Oncology
Highest Development Status : Phase II
Recipient : Instituto do Cancer do Estado de São Paulo
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Candesartan Cilexetil
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Recipient : Hospital Israelita Albert Einstein
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 27, 2023
Lead Product(s) : Candesartan Cilexetil
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Recipient : Hospital Israelita Albert Einstein
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Methotrexate
Therapeutic Area : Immunology
Study Phase : Phase I/ Phase II
Recipient : University of São Paulo General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 10, 2020
Lead Product(s) : Methotrexate
Therapeutic Area : Immunology
Highest Development Status : Phase I/ Phase II
Recipient : University of São Paulo General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fluticasone Propionate
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene
Details : Undisclosed
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
April 03, 2020
Lead Product(s) : Fluticasone Propionate
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Mometasone Furoate
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates
Details : Undisclosed
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
February 17, 2020
Lead Product(s) : Mometasone Furoate
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable